Clinical Trial Update: A Study of AL58805 in Patients With Advanced Tumors [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating AL58805 in patients with advanced tumors; the study is currently recruiting sponsored by Advenchen Laboratories Nanjing Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• AL58805

Snippet

Sponsor: Advenchen Laboratories Nanjing Ltd. | Conditions: Advanced Tumors | Phase 1 | Status: RECRUITING